IART R&D Expense Growth
Integra Lifesciences Holdings Corp · R&D Expense Growth
IART R&D Expense Growth
Latest reported-14.22%period ending
IART FY R&D Growth (YoY) (0.00% → -14.22%)
Latest values, visible window
High-resolution chart · PNG
IART r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -14.2195% | |
| 10.735% | |
| 2.9636% | |
| 8.75% | |
| 20.2504% | |
| -2.7547% | |
| 1.9631% | |
| 22.9864% | |
| 9.1136% | |
| 14.2647% | |
| -1.3586% | |
| -0.9446% | |
| 2.1093% | |
| -0.8532% | |
| 6.9356% | |
| 8.6585% | |
| -26.8039% | |
| 97.3221% | |
| 19.1435% | |
| 115.1505% | |
| -15.3034% | |
| 10.1998% | |
| 54.3112% | |
| 3.9039% | |
| 6.2201% | |
| -13.5172% | |
| 3.5714% | |
| 31.25% | |
| 1.5873% | |
| 21.1538% | |
| 0% |